NCT06090487View on ClinicalTrials.gov

Is Sacubitril-valsartan Superior to Dapagliflozin in Improving Myocardial Function Performance

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2024

Conditions
Heart Failure
Interventions
DIAGNOSTIC_TEST

myocardial function after surgery

This group includes (15) patients who will have 200 mg twice daily oral (5) sacubitril-valsartan 1 month before the operation. transthoracic echo will be done before and after surgery, also total dose if inoptropic drugs will be noted

Trial Locations (1)

Unknown

Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06090487 - Is Sacubitril-valsartan Superior to Dapagliflozin in Improving Myocardial Function Performance | Biotech Hunter | Biotech Hunter